Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing.

biomarkers disclosure ethics and policy preclinical Alzheimer's disease

Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
10 2022
Historique:
revised: 07 01 2022
received: 05 11 2021
accepted: 11 01 2022
pubmed: 26 2 2022
medline: 21 10 2022
entrez: 25 2 2022
Statut: ppublish

Résumé

Alzheimer's disease (AD) begins with an asymptomatic "preclinical" phase, in which abnormal biomarkers indicate risk for developing cognitive impairment. Biomarker information is increasingly being disclosed in research settings, and is moving toward clinical settings with the development of cheaper and non-invasive testing. Limited research has focused on the safety and psychological effects of disclosing biomarker results to cognitively unimpaired adults. However, less is known about how to ensure equitable access and robust counseling for decision-making before testing, and how to effectively provide long-term follow-up and risk management after testing. Using the framework of Huntington's disease, which is based on extensive experience with disclosing and managing risk for a progressive neurodegenerative condition, this article proposes a conceptual model of pre-disclosure, disclosure, and post-disclosure phases for AD biomarker testing. Addressing research questions in each phase will facilitate the transition of biomarker testing into clinical practice.

Identifiants

pubmed: 35213786
doi: 10.1002/alz.12620
pmc: PMC9402800
mid: NIHMS1773175
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1969-1979

Subventions

Organisme : NIH HHS
ID : NIA U24 AG057437
Pays : United States
Organisme : NIA NIH HHS
ID : U24 AG057437
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG062307
Pays : United States
Organisme : NIH HHS
ID : P30 AG062715
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG057784
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001414
Pays : United States
Organisme : NIH HHS
ID : RF1 AG057784
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062715
Pays : United States
Organisme : NIH HHS
ID : NCATS UL1 TR001414
Pays : United States
Organisme : NIA NIH HHS
ID : R03 AG062975
Pays : United States
Organisme : NIH HHS
ID : R01 AG070883
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066519
Pays : United States
Organisme : NIH HHS
ID : P30 AG066519
Pays : United States
Organisme : NIH HHS
ID : R01 AG054059
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG057547
Pays : United States
Organisme : NIH HHS
ID : R03 AG062975
Pays : United States
Organisme : NIH HHS
ID : RF1 AG057547
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG070883
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG054059
Pays : United States
Organisme : NIH HHS
ID : R01AG062307
Pays : United States

Informations de copyright

© 2022 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Références

Am J Med Genet. 1992 Feb 15;42(4):508-15
pubmed: 1535178
Alzheimers Dement (Amst). 2021 Feb 23;13(1):e12130
pubmed: 33665337
J Am Geriatr Soc. 2021 Jul;69(7):2044-2047
pubmed: 33960399
Am J Med Genet B Neuropsychiatr Genet. 2017 Jan;174(1):75-92
pubmed: 27174011
J Alzheimers Dis. 2018;62(2):487-498
pubmed: 29480179
Alzheimers Res Ther. 2020 Aug 12;12(1):95
pubmed: 32787971
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
JAMA Neurol. 2021 Apr 1;78(4):379-380
pubmed: 33393982
New Genet Soc. 2011 Winter;30(1):59-72
pubmed: 21603253
Ann Epidemiol. 2003 Jul;13(6):472-8
pubmed: 12875807
Maturitas. 2011 Jan;68(1):34-46
pubmed: 21093996
Am J Public Health. 2019 Jan;109(S1):S16-S20
pubmed: 30699025
Neurology. 2013 Sep 24;81(13):1114-21
pubmed: 23966249
JAMA. 2001 Jun 6;285(21):2750-6
pubmed: 11386931
JAMA Neurol. 2020 Dec 1;77(12):1504-1513
pubmed: 32777010
Alzheimers Dement. 2017 Sep;13(9):1024-1030
pubmed: 28263740
Clin Genet. 2013 Mar;83(3):221-31
pubmed: 22642570
Alzheimers Res Ther. 2013 Sep 06;5(5):43
pubmed: 24010759
Health Psychol. 2004 Mar;23(2):189-97
pubmed: 15008664
J Alzheimers Dis. 2015;49(3):617-31
pubmed: 26484931
Alzheimers Dement. 2018 Aug;14(8):981-988
pubmed: 29802030
JAMA Neurol. 2015 Dec;72(12):1484-90
pubmed: 26501506
J Alzheimers Dis. 2018;66(4):1309-1322
pubmed: 30507575
J Alzheimers Dis. 2021;79(3):1327-1344
pubmed: 33427747
Eur J Hum Genet. 2000 Oct;8(10):731-8
pubmed: 11039571
Eur J Ageing. 2012 Sep 22;9(4):275-284
pubmed: 28804427
J Alzheimers Dis. 2018;62(1):145-155
pubmed: 29439325
Alzheimer Dis Assoc Disord. 2019 Jul-Sep;33(3):246-253
pubmed: 31058683
Am J Geriatr Psychiatry. 2010 Mar;18(3):193-203
pubmed: 20224516
Alzheimers Dement. 2016 Apr;12(4):454-8
pubmed: 26750717
Alzheimers Dement. 2018 Jul;14(7):925-932
pubmed: 29602733
PLoS One. 2020 Feb 13;15(2):e0229137
pubmed: 32053667
Nat Rev Neurol. 2018 Nov;14(11):639-652
pubmed: 30297701
JAMA Neurol. 2022 Mar 1;79(3):219-220
pubmed: 34982103
J Nucl Med. 2013 Mar;54(3):476-90
pubmed: 23359661
J Med Ethics. 2018 Dec;44(12):830-834
pubmed: 30154216
J Prev Alzheimers Dis. 2021;8(4):398-410
pubmed: 34585212
N Engl J Med. 2009 Jul 16;361(3):245-54
pubmed: 19605829
Am J Psychiatry. 2014 Feb;171(2):201-8
pubmed: 24170170
Eur J Hum Genet. 2005 Sep;13(9):1077-85
pubmed: 15999117
Alzheimers Dement. 2022 Aug;18(8):1545-1564
pubmed: 34870885
Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317520904551
pubmed: 32052640
Mov Disord. 2019 Jun;34(6):858-865
pubmed: 30868663
Alzheimers Dement. 2021 Jul;17(7):1145-1156
pubmed: 33491853
Alzheimers Res Ther. 2015 May 12;7(1):26
pubmed: 25969699
Neurobiol Aging. 2016 Mar;39:147-53
pubmed: 26923411
Sociol Health Illn. 2018 Jul;40(6):969-987
pubmed: 29659032
JAMA Neurol. 2018 Jan 1;75(1):44-50
pubmed: 29059270
JAMA Neurol. 2019 Mar 1;76(3):251-253
pubmed: 30615027
Alzheimers Res Ther. 2018 Jul 28;10(1):72
pubmed: 30055660
Alzheimers Dement (N Y). 2019 Nov 06;5:705-716
pubmed: 31921963
J Med Genet. 1993 Dec;30(12):1023-7
pubmed: 8133501
Soc Sci Med. 2022 Jan;292:114620
pubmed: 34883313
Alzheimers Dement (Amst). 2021 Feb 20;13(1):e12150
pubmed: 33665341
Handb Clin Neurol. 2018;148:395-408
pubmed: 29478590
Alzheimers Dement (N Y). 2021 Oct 14;7(1):e12213
pubmed: 34692986
J Am Geriatr Soc. 2021 Nov;69(11):3203-3211
pubmed: 34252201
J Alzheimers Dis. 2021;79(2):559-572
pubmed: 33337371
Lancet Neurol. 2020 Jan;19(1):61-70
pubmed: 31706889
Alzheimers Dement. 2019 Feb;15(2):292-312
pubmed: 30555031
Alzheimers Dement. 2019 Dec;15(12):1533-1545
pubmed: 31601516
Alzheimers Dement. 2018 Feb;14(2):121-129
pubmed: 29233480
Alzheimers Res Ther. 2016 Dec 13;8(1):55
pubmed: 27955707
Rand Health Q. 2019 May 16;8(3):2
pubmed: 31205802
Neurology. 2013 Feb 19;80(8):764-72
pubmed: 23420894
JAMA Neurol. 2020 Jun 1;77(6):735-745
pubmed: 32250387
Alzheimers Dement (N Y). 2018 May 24;4:243-251
pubmed: 29955667
Neurology. 2011 Oct 11;77(15):1487-93
pubmed: 21917767
Prev Med. 2011 Sep;53(3):144-6
pubmed: 21723312
Alzheimers Dement. 2017 Apr;13(4):374-380
pubmed: 28314660
Genet Med. 2012 Aug;14(8):742-8
pubmed: 22498844
Mol Genet Genomic Med. 2020 Jan;8(1):e1026
pubmed: 31701651
J Law Biosci. 2021 May 19;8(1):lsab004
pubmed: 34040780
Alzheimers Dement. 2022 Oct;18(10):1969-1979
pubmed: 35213786
J Neurol Sci. 2019 Jan 15;396:52-68
pubmed: 30419368
Community Genet. 2002;5(2):128-37
pubmed: 12739519
Mayo Clin Proc. 2014 Oct;89(10):1389-96
pubmed: 25171823
Genet Med. 2004 Jul-Aug;6(4):197-203
pubmed: 15266207

Auteurs

Fred B Ketchum (FB)

Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Nathaniel A Chin (NA)

Division of Geriatrics, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Wisconsin Alzheimer's Disease Research Center, Madison, Wisconsin, USA.

Joshua Grill (J)

Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, Irvine, California, USA.
Departments of Psychiatry and Human Behavior and Neurobiology and Behavior, University of California, Irvine, Irvine, California, USA.

Carey E Gleason (CE)

Division of Geriatrics, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Wisconsin Alzheimer's Disease Research Center, Madison, Wisconsin, USA.
Geriatric Research, Education and Clinical Center (11G), William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin, USA.

Claire Erickson (C)

Wisconsin Alzheimer's Disease Research Center, Madison, Wisconsin, USA.
Neuroscience & Public Policy Program, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Lindsay R Clark (LR)

Division of Geriatrics, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Jane S Paulsen (JS)

Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Amy J H Kind (AJH)

Division of Geriatrics, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Wisconsin Alzheimer's Disease Research Center, Madison, Wisconsin, USA.
Center for Health Disparities Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH